Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-25 @ 9:29 PM
Study NCT ID:
NCT06388551
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-29
First Post:
2024-04-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017
Sponsor:
Luye Pharma Group Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-24
First Submit QC Date:
None
Study First Post Date:
2024-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-24
Last Update Post Date:
2024-04-29
Last Update Post Date Type:
ACTUAL